SCHEMBL8734189

SCHEMBL8734189

O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(S(=O)(=O)c3ccccc3)s1)C2

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 14/20 0.64
GBA1 P04062 1/20 0.41
MMP8 P22894 2/20 0.38
MMP3 P08254 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8731670 0.87 TBXA2R (0.82) TBXA2RGBA1
SCHEMBL8734192 0.82 TBXA2R (0.49) TBXA2RGBA1
SCHEMBL8734706 0.82 TBXA2R (0.82) TBXA2R
SCHEMBL8734677 0.79 TBXA2R (0.84) TBXA2R
SCHEMBL6532391 0.79 TBXA2R (0.66) TBXA2R
SCHEMBL8730048 0.78 TBXA2R (0.70) TBXA2R
SCHEMBL8733779 0.78 TBXA2R (0.70) TBXA2RMMP3
SCHEMBL8734661 0.78 TBXA2R (0.70) TBXA2R
SCHEMBL8730165 0.78 TBXA2R (0.70) TBXA2R
SCHEMBL8734691 0.78 TBXA2R (0.70) TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750524-A ADMINISTERING AN SULFAMIDE SUBSTITUTED INDAN DERIVATIVE ZERIA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
EP-0773019-A1 HYPERLIPEMIA REMEDY ZERIA PHARMACEUTICAL CO., LTD. (JP) 1997-05-14 EP disclosed